“Quad” Approved by FDA

This week, the FDA approved the once-daily, single-pill regimen formerly known as “Quad” (tenofovir/FTC/elvitegravir/cobicistat) for initial treatment of HIV infection. How much traction will it get in the clinic? Dr. Paul Sax shares his perspective in his blog HIV and ID Observations.